924P HANNA: Effectiveness and quality-of-life data from a real-world study of patients with recurrent and/or metastatic squamous cell carcinoma of the head and neck (R/M SCCHN) treated with nivolumab in Germany
2021
-
Correction
-
Source
-
Cite
-
Save
0
References
0
Citations
NaN
KQI